HuMurine Technologies was established as a spin-off company in 2008 by Dr. Gerold Feuer, formerly an Associate Professor in the Department of Microbiology and Immunology and the founder and former director of the Humanized SCID Mouse Center and Stem Cell Processing Lab at SUNY Upstate Medical University. HuMurine works closely with clients and academic partners to implement and facilitate humanized mouse models into commercial applications. Our staff and scientific advisors have over 30 years of combined experience and expertise in humanized mouse models and complex flow cytometric analyses, and we continue to explore new models and refine our existing models to prepare for the ever-changing landscape of preclinical research.
Dr. Gerold Feuer, Ph.D.
Founder and Chief Scientific Officer
Dr. Gerold Feuer is the Founder of HuMurine Technologies and serves as its CSO. He was previously an Associate Professor in the Department of Microbiology and Immunology at SUNY Upstate Medical University, and was the former Founder and Director of SUNY UMU’s Center for Humanized SCID Mouse Models. Dr. Feuer has worked with humanized mouse models since 1991, including the development of the first humanized mouse model to study HIV infection. Dr. Feuer has authored over 35 peer-reviewed research articles and reviews, and was awarded two contracts totaling over $6 million from the New York State Stem Cell Initiative (NYSTEM) to expand, develop and standardize new humanized mouse models for infectious diseases and stem cell therapies. Dr. Feuer received a BA from U.C. Berkeley and a Ph.D. from U.C. Irvine. He was a Special Fellow of the Leukemia and Lymphoma Society while a postdoctoral fellow in the laboratory of Dr. Irvin Chen at the UCLA School of Medicine.
Dr. Jenny Rowe, Ph.D.
Director of Laboratory Operations
Dr. Jenny Rowe joined HuMurine as the Director of Lab Operations in the fall of 2010. A virologist by training Dr. Rowe has extensive experience in the field of humanized mouse models including the development of a Hu-SCID mouse model to test novel therapeutic targets against human herpes viruses. Dr. Rowe received a BS from U.C. San Diego and a Ph.D. from SUNY Upstate Medical University.
Scientific Advisory Board
Dr. Jerome Zack, Ph.D.
Dr. Jerome Zack is a Professor in the Division of Hematology-Oncology, Department of Medicine, and Department of Microbiology, Immunology & Molecular Genetics at the David Geffen School of Medicine at UCLA. He also serves as the Associate Director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, where he is the Director of the Human Embryonic Stem Cell Bank. Dr. Zack is also the Director of the UCLA Center for AIDS Research (CFAR) and has made seminal contributions in the fields of virology, immunology and stem cell research. His lab has pioneered the modeling of HIV-1 pathogenesis and stem cell gene therapy for AIDS in SCID-hu chimeric mice. Dr. Zack has over a 100 peer-reviewed research articles and has received numerous national and international awards.
Dr. Craig Jordan, Ph.D.
Dr. Craig Jordan is Nancy Carol Allen Professor of Hematology and Chief, Division of Hematology, Hematologic Malignancies, and Stem Cell Transplantation at the University of Colorado Anschutz Medical Campus. His lab has pioneered research on leukemic stem cells and their therapeutic targeting in order to understand the complexity of the emerging paradigm of cancer stem cells. Dr. Jordan has published over 70 peer-reviwed research articles and has received numerous awards including the Leukemia and Lymphoma Society Stohlman Scholar award.
Dr. Ralph Feuer, Ph.D.
Dr. Ralph Feuer is an Associate Professor of Cell & Molecular Biology in the Department of Biology at San Diego State University. Dr. Feuer was trained in viral pathogenesis at the Scripps Research Institute. Dr. Feuer’s lab focuses on studying coxsackievirus tropism, persistence, and pathogenesis in the central nervous system (CNS). Dr. Feuer is the Director of SDSU/CIRM Stem Cell Internship Program and has published over 25 peer-reviewed research articles.